A population-based cohort study of effectiveness study of first, second, and third COVID-19 vaccine in solid organ transplant recipients
Latest Information Update: 23 May 2022
At a glance
- Drugs AZD 1222 (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
Most Recent Events
- 23 May 2022 New trial record
- 16 May 2022 Results published in the American Journal of Transplantation